Journal of Immunology Research
Volume 2020 (2020), Article ID 5106904, 3 pages
https://doi.org/10.1155/2020/5106904

Corrigendum

Corrigendum to “Tumor-Derived CXCL1 Promotes Lung Cancer Growth via Recruitment of Tumor-Associated Neutrophils”

Journal of Immunology Research

Received 21 July 2020; Accepted 22 July 2020; Published 13 August 2020

Copyright © 2020 Journal of Immunology Research. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

The article titled “Tumor-Derived CXCL1 Promotes Lung Cancer Growth via Recruitment of Tumor-Associated Neutrophils” [1] was reassessed due to concerns raised with research by Xuetao Cao [2]. The editorial board identified a figure duplication in the top two panels of Figure 4(c), which the authors explained was a mistake introduced during initial manuscript preparation and figure assembly.

The experiment was repeated by Dr. Mingyan Huang and supervised by Prof. Nan Li of the National Key Laboratory of Medical Immunology, Second Military Medical University. The corrected Figure 4(c) is shown below.

Figure 4: Tumor-infiltrating neutrophils in tumor inhibit T cell proliferation. (c) Fas/FasL expression on splenic CD11b⁺Ly6G⁺ neutrophils or TANs from 3LL/NC bearing mice, 3LL/shCXCL1 bearing, or naïve mice were analyzed by cytometric analysis.

Supplementary Materials

The electronic laboratory notes for the repeated experiments are available as supplementary materials. (Supplementary Materials)

References

M. Yuan, H. Zhu, J. Xu, Y. Zheng, X. Cao, and Q. Liu, “Tumor-derived CXCL1 promotes lung cancer growth via recruitment of tumor-associated neutrophils,” Journal of Immunology Research, vol. 2016, Article ID 6530410, 11 pages, 2016.

A. Silver, “Chinese ministry investigates duplications in papers by university president,” Nature, vol. 576, no. 7785, pp. 16-17.